deltatrials
Recruiting OBSERVATIONAL NCT06760923

Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

Sponsor: Xiangya Hospital of Central South University

Updated 1 time since 2025 Last updated: Jan 6, 2025 Started: Jan 1, 2025 Primary completion: Dec 31, 2026 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Ovarian Cancer (OvCa) and is currently actively recruiting participants. Xiangya Hospital of Central South University leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Feb 2025 – present · 19 months · monthly snapshotRecruiting

Change History

1 version recorded
Recruiting [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Xiangya Hospital of Central South University
Data source: Xiangya Hospital of Central South University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations